Osteopontin, angiogenesis and multiple myeloma
- 6 October 2005
- journal article
- editorial
- Published by Springer Nature in Leukemia
- Vol. 19 (12) , 2203-2205
- https://doi.org/10.1038/sj.leu.2403978
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Angiopoietin-1 and Myeloma-Induced AngiogenesisLeukemia & Lymphoma, 2005
- Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansionBlood, 2004
- Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implicationsBritish Journal of Haematology, 2003
- Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesisBlood, 2003
- Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignanciesSeminars in Oncology, 2001
- The Hallmarks of CancerCell, 2000
- Mice Lacking Osteopontin Show Normal Development and Bone Structure but Display Altered Osteoclast Formation In VitroJournal of Bone and Mineral Research, 1998
- Altered wound healing in mice lacking a functional osteopontin gene (spp1).Journal of Clinical Investigation, 1998
- Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontinBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1996
- Bone marrow angiogenesis and progression in multiple myelomaBritish Journal of Haematology, 1994